IL18 and neoplasm: IL-18 in combination with IL-12 can activate cytotoxic T cells (CTLs), as well as natural killer (NK) cells, to produce IFN-γ and, therefore, may contribute to tumor immunity (Esmailbeig et al., 2017; Kuppala et al., 2012).